Mersana Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Mersana Therapeutics stock had an average target of $30.38, with a low estimate of $30 and a high estimate of $30.75.

Price Target: $30.38 (+4.47%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$30	$30.38	n/a	$30.75
Change	+3.16%	+4.47%	n/a	+5.74%

Analyst Ratings

The average analyst rating for Mersana Therapeutics stock from 5 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

23.76M

from 40.50M

-41.32%

from 40.50M

Revenue Next Year

20.89M

from 23.76M

-12.07%

from 23.76M

EPS This Year

-8.50

from -14.12

EPS Next Year

-9.84

from -8.50

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	828.00K	43.00K	26.58M	36.86M	40.50M	23.76M	20.89M
Revenue Growth	-98.03%	-94.81%	61,716.28%	38.65%	9.88%	-41.32%	-12.07%
EPS	-35.80	-60.24	-54.51	-36.96	-14.12	-8.50	-9.84
No. Analysts	-	-	-	-	-	10	10

Revenue Forecast

Revenue	2025	2026
High	37.8M	44.9M
Avg	23.8M	20.9M
Low	14.7M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-6.7%	89.1%
Avg	-41.3%	-12.1%
Low	-63.7%	-

EPS Forecast

EPS	2025	2026
High	-1.87	-0.75
Avg	-8.50	-9.84
Low	-14.90	-16.51

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-